首页|布地奈德及孟鲁司特钠治疗支气管哮喘患儿试点研究:基于趣味性呼吸康复训练

布地奈德及孟鲁司特钠治疗支气管哮喘患儿试点研究:基于趣味性呼吸康复训练

扫码查看
目的 探讨趣味性呼吸康复训练(IRRT)联合布地奈德及孟鲁司特钠治疗支气管哮喘(BA)的临床疗效。方法 本研究是一个试点类临床研究,前瞻性招募 2023 年 1 月至 12 月安徽省马鞍山十七冶医院儿科就诊的BA患儿为研究对象。采用随机数字表法,将BA患儿随机分为IRRT组和常规组。连续干预 8 周,评估BA患儿治疗后临床疗效、相关症状恢复情况及不良反应情况;组内比较IRRT组和常规组治疗前后肺功能参数、炎症指标和生活质量变化情况,组间比较IRRT组和常规组治疗后肺功能参数、炎症指标和生活质量变化情况。结果 研究共纳入 120例BA患儿,每组各 60 例。治疗前,两组年龄、性别等基线资料差异均无统计学意义(P>0。05)。治疗 8周后,IRRT组和常规组BA患儿肺功能指标、炎症指标和生活质量有改善(P<0。05),且IRRT组改善程度优于常规组(P<0。05)。此外,IRRT组BA患儿喘息消失时间、哮鸣音消失时间、咳嗽消失时间和呼吸困难消失时间明显短于常规组(P<0。05)。在安全性方面,IRRT组和常规组患儿均未见严重不良反应。结论 IRRT辅助治疗可显著改善患儿的肺功能,降低炎症因子水平,缩短病程,提高生活质量促进患儿的早期康复。
Pilot study of budesonide and montelukast sodium in the treatment of children with bronchial asthma based on interesting respiratory rehabilitation training
Objective To investigate the clinical efficacy of interesting respiratory rehabilitation training(IRRT)combined with budesonide and montelukast sodium in the treatment of bronchial asthma(BA).Methods This is a pilot clinical research.Children with BA who visited Ma'anshan Shiqiye Hospital of Anhui province from January 2023 to December 2023 in were prospectively recruited as study subjects,and were divided into the IRRT group and the conventional group according to the random number table method.After 8 weeks of continuous intervention,the clinical efficacy,recovery of related symptoms and adverse reactions of BA children were evaluated.The changes in lung function parameters,inflammation indicators and quality of life were compared before and after treatment in the IRRT group and the conventional group,and the changes in lung function parameters,inflammation indicators and quality of life between the IRRT group and the conventional group after treatment were compared.Results A total of 120 BA children were included in the study,with 60 cases in each group.Before treatment,there was no significant difference in baseline data such as age and gender between the two groups(P>0.05).After 8 weeks of treatment,pulmonary function parameters,inflammation indicators,and quality of life were all improved in the IRRT group and the conventional group,(P<0.05),and the improvement in the IRRT group was better than that in the conventional group(P<0.05).In addition,the disappearance time of wheezing,disappearance time of cough,and disappearance time of dyspnea were significantly shorter than those in the conventional group(P<0.05).In terms of safety,no significant serious adverse effects were seen in the IRRT group and the conventional group.Conclusion Adjuvant IRRT therapy can significantly improve children's lung function,reduce the level of inflammatory factors,shorten the course of the disease,improve quality of life,and promote early recovery in children.

Bronchial asthmaInteresting respiratory rehabilitation trainingBudesonideMontelukast sodiumLung functionInflammatory factors

王学红、易晓琴、袁燕华

展开 >

马鞍山十七冶医院儿科(安徽马鞍山 243000)

支气管哮喘 趣味性呼吸康复训练 布地奈德 孟鲁司特钠 肺功能 炎症因子

马鞍山市科技计划项目

YL-2022-28

2024

中国药师
国家药品监督管理局高级研修学院,武汉医药(集团)股份有限公司

中国药师

CSTPCD
影响因子:0.944
ISSN:1008-049X
年,卷(期):2024.27(7)